Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel 2-weeks vs 3-weeks in HER2- MBC
NCT03147963Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Dec 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
docetaxel
Beyond the preview
Go deeper on NCT03147963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03147963.